Citigroup’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.11M Buy
548,057
+20,499
+4% +$116K ﹤0.01% 1752
2025
Q1
$2.51M Sell
527,558
-86,163
-14% -$410K ﹤0.01% 1915
2024
Q4
$3.42M Sell
613,721
-2,947
-0.5% -$16.4K ﹤0.01% 1728
2024
Q3
$3.9M Buy
616,668
+126,332
+26% +$798K ﹤0.01% 1525
2024
Q2
$2.08M Buy
490,336
+6,282
+1% +$26.6K ﹤0.01% 1740
2024
Q1
$3.51M Buy
484,054
+33,707
+7% +$244K ﹤0.01% 1456
2023
Q4
$2.26M Buy
450,347
+347
+0.1% +$1.74K ﹤0.01% 1562
2023
Q3
$1.89M Buy
450,000
+250,000
+125% +$1.05M ﹤0.01% 1497
2023
Q2
$806K Buy
+200,000
New +$806K ﹤0.01% 2394
2022
Q2
Sell
-3,477
Closed -$27K 5355
2022
Q1
$27K Buy
+3,477
New +$27K ﹤0.01% 4266
2021
Q2
Sell
-168
Closed -$8K 5398
2021
Q1
$8K Sell
168
-304
-64% -$14.5K ﹤0.01% 5074
2020
Q4
$18K Buy
472
+356
+307% +$13.6K ﹤0.01% 4679
2020
Q3
$3K Sell
116
-309
-73% -$7.99K ﹤0.01% 4817
2020
Q2
$31K Sell
425
-773
-65% -$56.4K ﹤0.01% 3977
2020
Q1
$63K Buy
1,198
+309
+35% +$16.3K ﹤0.01% 3602
2019
Q4
$73K Sell
889
-248
-22% -$20.4K ﹤0.01% 3726
2019
Q3
$64K Sell
1,137
-982
-46% -$55.3K ﹤0.01% 3654
2019
Q2
$253K Buy
2,119
+1,512
+249% +$181K ﹤0.01% 3076
2019
Q1
$111K Sell
607
-7,082
-92% -$1.3M ﹤0.01% 3504
2018
Q4
$1.37M Buy
7,689
+2,136
+38% +$381K ﹤0.01% 1791
2018
Q3
$1.78M Buy
5,553
+1,805
+48% +$578K ﹤0.01% 1584
2018
Q2
$1.5M Buy
3,748
+445
+13% +$178K ﹤0.01% 1633
2018
Q1
$1.19M Sell
3,303
-1,383
-30% -$496K ﹤0.01% 1724
2017
Q4
$1.86M Buy
4,686
+768
+20% +$304K ﹤0.01% 1528
2017
Q3
$1.67M Buy
3,918
+3,900
+21,667% +$1.66M ﹤0.01% 1608
2017
Q2
$3K Buy
18
+10
+125% +$1.67K ﹤0.01% 4428
2017
Q1
$1K Hold
8
﹤0.01% 4692
2016
Q4
$1K Hold
8
﹤0.01% 4786
2016
Q3
$1K Hold
8
﹤0.01% 4818
2016
Q2
$0 Sell
8
-367
-98% ﹤0.01% 4927
2016
Q1
$24K Buy
375
+236
+170% +$15.1K ﹤0.01% 4536
2015
Q4
$12K Buy
+139
New +$12K ﹤0.01% 4710
2015
Q3
Sell
-5
Closed -$1K 5186
2015
Q2
$1K Buy
+5
New +$1K ﹤0.01% 5294